Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs
A linear type of several low molecular weight CXCR4 antagonists were developed based on T140 analogs, which were previously found to be strong CXCR4 antagonists that block X4-HIV-1 entry and have inhibitory activities against cancer metastasis/progression and rheumatoid arthritis. The Royal Society of Chemistry 2006.
Tamamura, Hirokazu,Tsutsumi, Hiroshi,Masuno, Hiroyuki,Mizokami, Satoko,Hiramatsu, Kenichi,Wang, Zixuan,Trent, John O.,Nakashima, Hideki,Yamamoto, Naoki,Peiper, Stephen C.,Fujii, Nobutaka
p. 2354 - 2357
(2008/09/18)
More Articles about upstream products of 905592-96-3